0001209191-22-003195.txt : 20220113
0001209191-22-003195.hdr.sgml : 20220113
20220113163602
ACCESSION NUMBER: 0001209191-22-003195
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220111
FILED AS OF DATE: 20220113
DATE AS OF CHANGE: 20220113
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sofinnova Partners SAS
CENTRAL INDEX KEY: 0001574139
STATE OF INCORPORATION: I0
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41201
FILM NUMBER: 22529419
BUSINESS ADDRESS:
STREET 1: 17 RUE DE SERENE
CITY: PARIS
STATE: I0
ZIP: 75008
BUSINESS PHONE: 33 1 53 05 41 13
MAIL ADDRESS:
STREET 1: 17 RUE DE SERENE
CITY: PARIS
STATE: I0
ZIP: 75008
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sofinnova Capital IX
CENTRAL INDEX KEY: 0001849915
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41201
FILM NUMBER: 22529418
BUSINESS ADDRESS:
STREET 1: 7-11 BOULEVARD HAUSSMANN
CITY: PARIS
STATE: I0
ZIP: 75009
BUSINESS PHONE: 33(0)1 76 23 41 00
MAIL ADDRESS:
STREET 1: 7-11 BOULEVARD HAUSSMANN
CITY: PARIS
STATE: I0
ZIP: 75009
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CinCor Pharma, Inc.
CENTRAL INDEX KEY: 0001868734
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 CLARENDON STREET, 6TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 8445311834
MAIL ADDRESS:
STREET 1: 200 CLARENDON STREET, 6TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-01-11
0
0001868734
CinCor Pharma, Inc.
CINC
0001574139
Sofinnova Partners SAS
7-11 BOULEVARD HAUSSMANN
PARIS
I0
75009
FRANCE
0
0
1
0
0001849915
Sofinnova Capital IX
7-11 BOULEVARD HAUSSMANN
PARIS
I0
75009
FRANCE
0
0
1
0
Common Stock
2022-01-11
4
C
0
3867646
A
3867646
I
By Sofinnova Capital IX
Common Stock
2022-01-11
4
P
0
220000
16.00
A
4087646
I
By Sofinnova Capital IX
Series A Preferred Stock
2022-01-11
4
C
0
9999999
0.00
D
Common Stock
2941176
0
I
By Sofinnova Capital IX
Series B Preferred Stock
2022-01-11
4
C
0
3150000
0.00
D
Common Stock
926470
0
I
By Sofinnova Capital IX
Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO") for no additional consideration, on a 3.4:1 basis, and had no expiration date.
The shares are directly held by Sofinnova Capital IX ("SC IX"). Sofinnova Partners SAS ("Sofinnova Partners") is the management company of SC IX and may be
deemed to share voting and investment power over the shares held by SC IX. Sofinnova Partners disclaims beneficial ownership of these shares except to the
extent of its pecuniary interest therein.
Sofinnova Partners SAS, By /s/ Monique Saulnier, Managing Partner
2022-01-13
Sofinnova Capital IX, By: Sofinnova Partners SAS, its management company, By /s/ Monique Saulnier, Managing Partner
2022-01-13